General Updates

7th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir/ Madam, Sub.: Receipt of Certified copy of Order passed by National Company Law Tribunal, Ahmedabad Bench (“NCLT”) regarding the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders Ref.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ==================================================================== This is further to our earlier intimation dated 6th July, 2026 in connection with Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“Transferor Company”) with Torrent Pharmaceuticals Limited (“Transferee Company”) and their respective shareholders (“Scheme”) under the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder. The Hon’ble National Company Law Tribunal, Ahmedabad Bench vide its Order dated 6th July, 2026, sanctioned the Scheme (“Order”). This is to inform you that the Company has received the certified true copy of the Order on 7th July, 2026 and the same is available on the Company’s website at www.torrentpharma.com Email – investorservices@torrentpharma.com Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com